Formulation of a CITE metric for evaluating the clinical implications of medical studies and their originating hospitals in China

Gao Jianchao, Chen Xiaoyuan, Gao Chenyan
{"title":"Formulation of a CITE metric for evaluating the clinical implications of medical studies and their originating hospitals in China","authors":"Gao Jianchao,&nbsp;Chen Xiaoyuan,&nbsp;Gao Chenyan","doi":"10.1002/hcs2.108","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The number of medical research publications by Chinese clinical investigators has risen substantially, contributing to 14.63% of the global total in 2019; however, their tangible impact on clinical decision-making remains limited. Various evaluation methods have been developed to measure hospital research competence in China, such as Fudan University's China hospital ranking and Science and Technology Evaluation Metrics (STEM) ranking, which predominantly focuses on factors such as academic reputation, volume of publications and patents, and research resources. However, composite indices may not fully capture the actual clinical value generated by medical research. To address this gap, we introduced the “Clinical Influence and Timeliness Evaluation (CITE)” metric to assess both the clinical importance of a given medical research study and the clinical influence of the hospital where it originated. The methodology used relies on the premise that influential medical research would be referenced in clinical guidelines, which serve as critical resources for clinicians.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The CITE metric was applied for 78,636 medical studies concerning chronic obstructive pulmonary disease (COPD) published between 2000 and 2020 and referenced in both Chinese and international clinical guidelines for COPD. Specific indexes and formulas were derived to quantify the clinical weight of a medical research study (W) and its timeliness (T), enabling a dynamic assessment of the clinical value of each study and the overall contribution of a particular hospital.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In this analysis, we incorporated 499 hospitals in China and quantitatively identified their dynamic clinical influence in COPD from 2000 to 2020. Our findings offer objective and targeted evaluation metrics by focusing on clinical relevance and recognizing the collaborative nature of medical research.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The CITE metric provides an innovative method to gauge the true impact of medical research in China, with potential applications across different medical specialties. CITE can serve as a useful tool for understanding the relationship between research input and practical clinical outcomes, ultimately promoting more clinically relevant research endeavors.</p>\n </section>\n </div>","PeriodicalId":100601,"journal":{"name":"Health Care Science","volume":"3 4","pages":"264-273"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hcs2.108","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Care Science","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hcs2.108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The number of medical research publications by Chinese clinical investigators has risen substantially, contributing to 14.63% of the global total in 2019; however, their tangible impact on clinical decision-making remains limited. Various evaluation methods have been developed to measure hospital research competence in China, such as Fudan University's China hospital ranking and Science and Technology Evaluation Metrics (STEM) ranking, which predominantly focuses on factors such as academic reputation, volume of publications and patents, and research resources. However, composite indices may not fully capture the actual clinical value generated by medical research. To address this gap, we introduced the “Clinical Influence and Timeliness Evaluation (CITE)” metric to assess both the clinical importance of a given medical research study and the clinical influence of the hospital where it originated. The methodology used relies on the premise that influential medical research would be referenced in clinical guidelines, which serve as critical resources for clinicians.

Methods

The CITE metric was applied for 78,636 medical studies concerning chronic obstructive pulmonary disease (COPD) published between 2000 and 2020 and referenced in both Chinese and international clinical guidelines for COPD. Specific indexes and formulas were derived to quantify the clinical weight of a medical research study (W) and its timeliness (T), enabling a dynamic assessment of the clinical value of each study and the overall contribution of a particular hospital.

Results

In this analysis, we incorporated 499 hospitals in China and quantitatively identified their dynamic clinical influence in COPD from 2000 to 2020. Our findings offer objective and targeted evaluation metrics by focusing on clinical relevance and recognizing the collaborative nature of medical research.

Conclusion

The CITE metric provides an innovative method to gauge the true impact of medical research in China, with potential applications across different medical specialties. CITE can serve as a useful tool for understanding the relationship between research input and practical clinical outcomes, ultimately promoting more clinically relevant research endeavors.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
制定用于评估中国医学研究及其原产医院临床意义的 CITE 指标
背景 中国临床研究人员发表的医学研究论文数量大幅增加,2019年占全球总数的14.63%;然而,这些论文对临床决策的实际影响仍然有限。目前已开发出多种评价方法来衡量中国医院的科研能力,如复旦大学的中国医院排名和科技评价指标(STEM)排名,主要关注学术声誉、论文和专利数量以及科研资源等因素。然而,综合指数可能无法完全反映医学研究产生的实际临床价值。为了弥补这一不足,我们引入了 "临床影响力和及时性评估(CITE)"指标,以评估特定医学研究的临床重要性和该研究所在医院的临床影响力。使用该方法的前提是,有影响力的医学研究会在临床指南中被引用,而临床指南是临床医生的重要资源。 方法 对 2000 年至 2020 年间发表的 78,636 项有关慢性阻塞性肺病(COPD)的医学研究应用 CITE 指标,这些研究被中国和国际慢性阻塞性肺病临床指南引用。得出了具体的指标和公式来量化医学研究的临床权重(W)和时效性(T),从而能够动态评估每项研究的临床价值和特定医院的整体贡献。 结果 在这项分析中,我们纳入了中国的 499 家医院,并定量确定了它们从 2000 年到 2020 年在慢性阻塞性肺病领域的动态临床影响力。我们的研究结果通过关注临床相关性和承认医学研究的合作性质,提供了客观和有针对性的评价指标。 结论 CITE 指标为衡量中国医学研究的真实影响力提供了一种创新方法,并有可能应用于不同的医学专业。CITE 可作为了解研究投入与实际临床成果之间关系的有用工具,最终促进更多与临床相关的研究工作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.90
自引率
0.00%
发文量
0
期刊最新文献
Study protocol: A national cross-sectional study on psychology and behavior investigation of Chinese residents in 2023. Caregiving in Asia: Priority areas for research, policy, and practice to support family caregivers. Innovative public strategies in response to COVID-19: A review of practices from China. Sixty years of ethical evolution: The 2024 revision of the Declaration of Helsinki (DoH). A novel ensemble ARIMA-LSTM approach for evaluating COVID-19 cases and future outbreak preparedness.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1